Skip to main content

Table 3 Factors associated with completed TLTBI. Univariate and multivariate analyses (n = 111)

From: Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

  Univariate
Analysis
Multivariate
Analysis
Variables Crude
OR
(95% CI) p value Adjusted OR (95% CI) P value
Sex       
   Female 1    1   
   Male 1.2 (0.9-1.6) 0.244 2.1 (0.9-4.9) 0.081
Age group (years)       
   19-29 1    1   
   30-34 1.1 (0.4-2.9) 0.808 1.2 (0.3-5.1) 0.789
   35-38 1.2 (0.4-3.5) 0.702 1.4 0.4-4.5) 0.599
   39-61 3.6 (1.1-11.9) 0.035 2.9 (0.6-13.1) 0.173
HIV transmission route       
   IDU 1    1   
   MSM 1.7 (0.2-12.3) 0.606 2.0 (0.3-12.2) 0.458
   Heterosexual 3.6 (1.3-9.8) 0.010 4.6 (1.4-14.7) 0.010
   Other/Unknown 1.0 (0.1-13.7) 0.979 1.3 (0.2-7.6) 0.793
Type of TLTBI       
   9H 1    1   
   6H 0.9 (0.3-2.9) 0.861 0.6 (0.2-2.2) 0.505
   12H 0.6 (1.1-2.2) 0.423 0.6 (0.2-1.9) 0.382
   2RZ 9.6 (1.1-81.4) 0.037 8.3 (2.7-24.9) 0.000
   3RH 1.9 (0.2-21.1) 0.591 1.7 (0.1-24.2) 0.702
  1. OR: Odds ratio; CI: confidence interval
  2. TLTBI: Treatment of latent tuberculosis infection; IDU: Intravenous drug user; MSM: Men who have sex with men; H: isoniazid; R: rifampin; Z: pyrazinamide
  3. Multivariate model adjusted by hospital